Test description
Testing of an expanded set of genes associated with the most common hereditary cancer syndromes in patients with complex or overlapping personal or family cancer histories.
Test information
BRAoVO™ Extended Cancer Gene Panel
- Testing of a patient with cancer where there is also a family history of one or more cancer types of breast, ovarian, colorectal, polyposis, pancreatic, endometrial and/or prostate cancers.
- Testing of an unaffected patient where there is a complex family history of two or more cancer types of breast, ovarian, colorectal, polyposis, pancreatic, endometrial and/or prostate cancers.
APC, ATM, AXIN2, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, CTNNA1, EPCAM, GREM1, HOXB13, KIT, MLH1, MLH3, MSH2, MSH3, MSH6, MUTYH, NF1, NTHL1, PALB2, PMS2, PMS2CL, POLD1, POLE, PTEN, RAD51C, RAD51D, RNF43, SCG5, SMAD4, STK11, TP53
Massively Parallel Sequencing
4 - 5 weeks
$650 if not Medicare eligible
Cancer Genetics Request form preferred. Standard pathology request form accepted.
Blood x 2
EDTA
2 x Bloods taken at 10 minute intervals. Pre-test genetic counselling required. Patient to sign a consent form prior to testing, to remain with specialist.